Even though no model will be perfect ... To get stories like this in your inbox first, sign up here. Long-acting HIV prevention meds: 10 Breakthrough Technologies 2025 In June 2024, results ...

HOUSTON — The fight against HIV has come a long way, and new advancements in prevention are changing the game. One of the latest breakthroughs is a long-lasting injectable form of PrEP (pre ...

the first two medications approved for the prevention of HIV; it led to widespread speculation of the end of HIV as an epidemic. And yet, more than a decade after the first approval for PrEP in ...

Thanks to advancements in prevention and treatment, global HIV infection rates have dramatically declined in recent years. But HIV still affects over 38 million people around the world.

When drugmaker Gilead Sciences announced interim late-stage trial results of its injectable HIV prevention drug last month, researchers, advocates and Wall Street collectively rejoiced.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

Public health, explained: Sign up to receive Healthbeat’s free Atlanta newsletter here. The sharp job cuts at the Centers for Disease Control and Prevention include a successful program reducing ...

The Food and Drug Administration is expected to decide by June 19 whether to approve the drug as a twice-yearly injection for HIV prevention. "We haven't seen or heard anything to date that would ...

Researchers analyzed 22 recent studies exploring HIV-related outcomes in the context of climate change and identified several links between extreme weather events and HIV prevention and care.

Concerns are growing after the Trump administration eliminated staff at the Centers for Disease Control and Prevention’s office for HIV prevention. Organizations working to combat HIV in ...

"Our contributions to this year's meeting demonstrate Gilead's leadership in person-centered innovations across HIV prevention, treatment, and cure. Our scientific advancements are grounded in ...

Cisgender Black women are disproportionately affected by HIV. The Centers for Disease Control and Prevention has awarded a $1.4 million grant to a University of Albany professor, Melonie Walcott ...